(Q45738401)

English

Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease

scientific article published in February 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease (English)

1 reference

Europe PubMed Central

15 December 2017

6

object named as

Slaoui M

1 reference

Europe PubMed Central

15 December 2017

author name string

Prince GA

1

1 reference

Europe PubMed Central

15 December 2017

Denamur F

2

1 reference

Europe PubMed Central

15 December 2017

Deschamps M

3

1 reference

Europe PubMed Central

15 December 2017

Garçon N

4

1 reference

Europe PubMed Central

15 December 2017

Prieels JP

5

1 reference

Europe PubMed Central

15 December 2017

Thiriart C

7

1 reference

Europe PubMed Central

15 December 2017

Porter DD

8

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

19

1 reference

Europe PubMed Central

15 December 2017

15-16

1 reference

Europe PubMed Central

15 December 2017

2048-2054

1 reference

Europe PubMed Central

15 December 2017

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunogenicity and pathogenicity of a triple temperature-sensitive modified respiratory syncytial virus in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The immunogenicity of subunit vaccines for respiratory syncytial virus after co-formulation with aluminum hydroxide adjuvant and recombinant interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Complete protection of mice from respiratory syncytial virus infection following mucosal delivery of synthetic peptide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of immunological factors in respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900417-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(00)00417-5

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45738401&oldid=2079856391"